News

Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in ‘big data’ pathology research.

Patients in NSW will now be able to view their pathology results through the My Health Record consumer portal and mobile applications.

A new optical diagnostic probe could enable the safe and non-invasive detection of breast cancer.

Currently, most patients with an intellectual disability receive no molecular diagnosis, which significantly affects their health and shortens their lifespan.

An approach that attracts and captures elusive immune disease cells in vivo could one day be used to better understand diabetes and other autoimmune disorders.

A Stanford-led team of researchers has developed tiny bubbles that bind to malignant tumors, making them visible to ultrasound imaging.

A blood test has been developed that could help clinicians identify infants who may have had bleeding of the brain as a result of abusive head trauma.

Penn State researchers have developed nanoprobes to rapidly isolate rare markers, called extracellular vesicles, for the potential development of precision cancer diagnoses and personalized anticancer treatments.

The acquisition is Aurora's tenth overall since 2013, and will help Aurora continue to expand its capabilities to serve hospitals.

Proprietary qPCR assay planned to be ready to market during 2018.